德国拜耳利伐沙班的安全性高吗

Rivaroxaban is the world's first oral direct factor Xa inhibitor, mainly used to treat venous thrombosis in adults. Compared with traditional anticoagulants, Rivaroxaban has accurate efficacy, does not require constant monitoring, has good safety and is easy to use. It is expected to become an alternative drug to heparin and vitamin K antagonists.

Is Germany's Bayer Rivaroxaban safe?

In a randomized, double-blind, controlled study, the clinical trial was divided into 3 groups, the first group of 1107 patients took 20 mg of Rivaroxaban, the second group of 1127 patients took 10 mg of Rivaroxaban, and the third group of 1131 patients took 100 mg of aspirin, these patients had completed 6 to 12 months of initial anticoagulation therapy.

After 12 months of continuous use, the recurrence rate of venous thrombosis in the aspirin group was 4.4%. The recurrence rates of Rivaroxaban 20 mg and 10 mg were significantly lower than those in the aspirin group, which were 1.5% and 1.2% respectively. Comparing the three groups, there were very few patients who experienced severe bleeding after taking the drug, which were 0.3%, 0.4% and 0.5% respectively. There was no statistical difference between the three groups. The clinically relevant non-bleeding events between the 3 groups were 2.7, 2.0, and 1.8 respectively, and there was also no statistical difference.

Headquartered in Leverkusen, Germany, Bayer has 750 production plants in 200 locations on six continents; it has 120,000 employees and 350 branches in almost every country in the world. Polymers, medicine and health care, chemical industry and agriculture are the company's four pillar industries.

The above is the introduction about Rivaroxaban. If patients have other questions about Rivaroxaban (such as drug prices, purchase channels, etc.), they can consult the medical companion travel service.

Recommended hot articles: /newsDetail/89877.html